Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

Mostrar otras versiones (1)

The COVID-19 pandemic, caused by SARS-CoV-2, is a pressing public health emergency garnering rapid response from scientists across the globe. Host cell invasion is initiated through direct binding of the viral spike protein to the host receptor angiotensin-converting enzyme 2 (ACE2). Disrupting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Quinlin M., Wilson, Kelli M., Shen, Min, Itkin, Zina, Eastman, Richard T., Shinn, Paul, Hall, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301901/
https://www.ncbi.nlm.nih.gov/pubmed/32577632
http://dx.doi.org/10.1101/2020.06.16.154708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301901/
https://www.ncbi.nlm.nih.gov/pubmed/32577632
http://dx.doi.org/10.1101/2020.06.16.154708

Ejemplares similares